KIT mutations are implicated in the pathogenesis of thymic carcinoma, and as such, CD117 positivity is found in approximately 80% of cases of thymic carcinoma and not found in other subtypes of thymoma [10,11]. The gene discussed is KIT; the disease is thymoma.